Skip to main content

What is Armored RNA Technology?

Armored RNA® and Armored DNA technologies stabilize and protect nucleic acids from nuclease degradation by packaging them in a protective protein coat. Armored reagents deliver several end-user benefits, including:

Optimized Workflow

Armored RNA, Armored RNA Quant and Armored DNA Quant controls can be added directly to human matrices as an exogenous internal control for extraction with most nucleic acid isolation methods and detection in molecular assays.

Flexibility

Nuclease-resistant protein coat can also be removed by heat lysis for direct detection as a positive run control. For Armored RNA Quant and Armored DNA Quant, analytical quantification is performed with a validated method referencing a NIST-traceable phosphate standard.

Catalog of Armored RNA and Armored DNA Products

Armored RNA Quant®

Each control encodes in vitro transcribed RNA encapsulated in a protective protein coat to create a virus-like particle resistant to nuclease degradation.

Product Description Part # Configuration
SARS-CoV-2 Targets the Nucleocapsid 1 and Nucleocapsid 2 regions of the CDC recommended Diagnostic Panel (CDC-006-00019). 52151 1x106 cp/mL
250μL
SARS-CoV-2 Panel Contains multiple regions of SARS-Cov-2 genome including nucleocapsid, envelope, RNA-dependent RNA polymerase, open reading frame 1, and human RNAse P as an internal control. 52153 1x106 cp/mL
250μL
SARS-CoV-2 Spike Variants Targets mutations in the SARS CoV-2 spike protein prevalent in the Alpha (B.1.1.7), Beta (B.1.351), Gamma (B.1.1.28), Delta (B.1.617.2), and Omicron (B.1.1.529) strains. 52160 1x106 cp/mL
250μL
Respiratory Triplex Contains regions of SARS-Cov-2, Influenza A (H1N1, H3N2, and H7N9), Influenza B, Respiratory Syncytial Virus A (RSVA), Respiratory Syncytial Virus B (RSVB), and RPP30 as an internal control. 52108 1x108 cp/mL
250μL
EPA-1615 Contains sequences detected by the Enterovirus, Norwalk GI, and Norwalk GII virus assays described in EPA Method 1615 - Measurement of Enterovirus and Norovirus occurrence in water by culture and RT-qPCR. 52000 1x1012 cp/mL
500μL
Enterovirus Contains sequences amplified by primer binding regions for polio virus (type I Sabin), coxsackievirus A and coxsackievirus B (Schwab, et al., 1995 and Rotbart, 1990). 42102 5x105 cp/mL
5x100μL
Pentavalent Arbovirus Control Targets regions of the Chikungunya, Dengue, West Nile, Yellow Fever, and Zika viruses. 49659 1x108 cp/mL
500μL
Zika Virus Targets regions of the Zika virus. 49610 5x105 cp/mL
500μL
Internal Process Control Targets a non-specific, 1,000 base pair in vitro transcribed RNA (non-homologous) sequence intended to be used as a spike-in to sample (e.g., urine, blood, CSF, plasma/liquid biopsy) to monitor the overall efficiency of a testing process.  49650 1x106 cp/mL
500μL
RNase P Targets the human RNase P gene; often used as an internal control because abundant copies in the human genome make it readily detectable. 52152 1x106 cp/mL
500μL

Armored DNA Quant™

Armored DNA  technology stabilizes and protects nucleic acids from nuclease degradation by packaging them in a protective protein coat. Encapsulated as non-infectious, nuclease-resistant, pseudo-viral particle.

 
Product Description Part # Configuration
Mpox/Nonvariola Orthopox Control

A single, concatenated construct of both nonvariola Orthopox and Mpox-specific sequence blended with with RNAse P to allow for an all-in-one process control. The control is provided as two tubes of high and low concentration along with diluent for convenience.

49670

500μL

Internal Process Control Targets a non-specific, 495 base pair in vitro transcribed DNA (non-homologous) sequence intended to be used as a spike-in to sample (e.g., urine, blood, CSF, plasma/liquid biopsy) to monitor the overall efficiency of a testing process. 52003 1x108 cp/mL
500μL

Armored RNA®

Product Description Part # Volume
Hepatitis G Virus Contains sequences amplified by primer binding regions for Hepatitis G Virus (Schlueter, 1996); the PCR product generated is 185 base pairs. 42024 250μL
Enterovirus Contains sequences amplified by primer binding regions for polio virus (type I Sabin), coxsackievirus A and coxsackievirus B (Schwab, et al., 1995 and Rotbart, 1990). 42050 250μL

Armored RNA Quant Made-to-Order

Description Part # Description Part #
Astrovirus 52214 Human Papillomavirus 16 52219
Bacteriophage MS2 52223 Human Papillomavirus 18 52220
Beta-Actin (ACTB) 52225 Norovirus GI.1 52215
Ebolavirus 52217 Norovirus GII.4 52216
Glucuronidase Beta (GUSB) 52224 Sapovirus I 52213
Hepatitis C Virus (GT 2b) 42101 Sapovirus I, II, IV 52221
Hepatitis D Virus 52212 Sapovirus V 52222
HIV (Subtype B) 42103 Sudan Ebolavirus 52218

Armored RNA® Made-to-Order

Description Part # Description Part #
Dengue Virus (Type I) 42044 Norovirus GI 42030
Hepatitis C Virus (GT 1a) 42004 Norovirus GII 42032
Hepatitis C Virus (GT 1b) 42006 SARS (BNI-1) 42090
Hepatitis C Virus (GT 2a/c) 42008 SARS (CoV-NC) 42091
Hepatitis C Virus (GT 2b) 42010 West Nile Virus (Cap) 42042
Hepatitis C Virus (GT 3a) 42012 West Nile Virus (HNY1999) 42040
HIV (Subtype B) 42000 West Nile Virus (NEN) 42041

Molecular Assay Reagents

†Variable concentrations, volumes and vial quantities available upon request
Product Description Part # Volume
RNARetain Buffer Intended for the collection, storage, and transportation of fresh tissue specimens for subsequent RNA isolation and further molecular testing. Eliminates the need to immediately process specimens, enabling RNA extraction and molecular testing at a later time and/or transport to a different location. 49536 Volume 2L
TSMIII Buffer A buffered solution ideally suited for the dilution of Armored products. The additives provide stability to the protein-coated nucleic acid through multiple freeze-thaws when stored properly, allowing for more flexible and scalable testing processes. 49600 Volume 50mL
scientist in asuragen lab

 

To Place an Order for Armored Molecular Controls,

send us an email.